Shibasaki Masayuki | Drug Discovery Research, Astellas Pharma, Inc., Japan
スポンサーリンク
概要
Drug Discovery Research, Astellas Pharma, Inc., Japan | 論文
- Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin–Nicotinamide-Induced Mildly Diabetic Mice
- Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin-Nicotinamide-Induced Mildly Diabetic Mice